Manzo Pharmaceut Stock Fundamentals
Manzo Pharmaceut fundamentals help investors to digest information that contributes to Manzo Pharmaceut's financial success or failures. It also enables traders to predict the movement of Manzo Stock. The fundamental analysis module provides a way to measure Manzo Pharmaceut's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Manzo Pharmaceut stock.
As of the 18th of December 2024, Selling General Administrative is likely to drop to about 2.6 M. In addition to that, Total Revenue is likely to drop to 1,722. Manzo | Select Account or Indicator |
Manzo Pharmaceut Company Shares Outstanding Analysis
Manzo Pharmaceut's Outstanding Shares are shares of common stock of a public company that were purchased by investors after they were authorized and issued by the company to the public. Outstanding Shares are typically reported on fully diluted basis, including exotic instruments such as options, or convertibles bonds.
Current Manzo Pharmaceut Shares Outstanding | 1.16 B |
Most of Manzo Pharmaceut's fundamental indicators, such as Shares Outstanding, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Manzo Pharmaceut is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Outstanding shares that are stated on company Balance Sheet are used when calculating many important valuation and performance indicators including Return on Equity, Market Cap, EPS and many others.
| Competition |
Based on the latest financial disclosure, Manzo Pharmaceut has 1.16 B of shares currently outstending. This is 36.82% lower than that of the Capital Markets sector and significantly higher than that of the Financials industry. The shares outstanding for all United States stocks is 102.78% lower than that of the firm.
Manzo Pharmaceut Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Manzo Pharmaceut's current stock value. Our valuation model uses many indicators to compare Manzo Pharmaceut value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Manzo Pharmaceut competition to find correlations between indicators driving Manzo Pharmaceut's intrinsic value. More Info.Manzo Pharmaceut is rated top company in current valuation category among its peers. It also is considered to be number one stock in shares outstanding category among its peers creating about 100,002 of Shares Outstanding per Current Valuation. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Manzo Pharmaceut's earnings, one of the primary drivers of an investment's value.Manzo Shares Outstanding Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Manzo Pharmaceut's direct or indirect competition against its Shares Outstanding to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Manzo Pharmaceut could also be used in its relative valuation, which is a method of valuing Manzo Pharmaceut by comparing valuation metrics of similar companies.Manzo Pharmaceut is currently under evaluation in shares outstanding category among its peers.
Manzo Fundamentals
| Current Valuation | 11.6 K | ||||
| Shares Outstanding | 1.16 B | ||||
| Revenue | 2.01 K | ||||
| Gross Profit | 20.97 K | ||||
| EBITDA | (4.24 M) | ||||
| Net Income | (36.24 K) | ||||
| Cash And Equivalents | 21 | ||||
| Total Debt | 11.09 K | ||||
| Current Ratio | 0.20 X | ||||
| Cash Flow From Operations | 275.76 K | ||||
| Number Of Employees | 12 | ||||
| Beta | -44.7 | ||||
| Market Capitalization | 11.6 K | ||||
| Total Asset | 192.41 K | ||||
| Retained Earnings | (12.4 M) | ||||
| Working Capital | 23 K | ||||
| Current Asset | 15 K | ||||
| Current Liabilities | (8 K) | ||||
| Net Asset | 192.41 K |
About Manzo Pharmaceut Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Manzo Pharmaceut's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Manzo Pharmaceut using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Manzo Pharmaceut based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.| Last Reported | Projected for Next Year | ||
| Total Revenue | 1.8 K | 1.7 K | |
| Cost Of Revenue | 1.1 K | 1 K |
Pair Trading with Manzo Pharmaceut
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Manzo Pharmaceut position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Manzo Pharmaceut will appreciate offsetting losses from the drop in the long position's value.The ability to find closely correlated positions to Manzo Pharmaceut could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Manzo Pharmaceut when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Manzo Pharmaceut - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Manzo Pharmaceut to buy it.
The correlation of Manzo Pharmaceut is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Manzo Pharmaceut moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Manzo Pharmaceut moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Manzo Pharmaceut can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Manzo Pharmaceut Piotroski F Score and Manzo Pharmaceut Altman Z Score analysis. To learn how to invest in Manzo Stock, please use our How to Invest in Manzo Pharmaceut guide.You can also try the Equity Analysis module to research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities.
Is Asset Management & Custody Banks space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Manzo Pharmaceut. If investors know Manzo will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Manzo Pharmaceut listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Manzo Pharmaceut is measured differently than its book value, which is the value of Manzo that is recorded on the company's balance sheet. Investors also form their own opinion of Manzo Pharmaceut's value that differs from its market value or its book value, called intrinsic value, which is Manzo Pharmaceut's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Manzo Pharmaceut's market value can be influenced by many factors that don't directly affect Manzo Pharmaceut's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Manzo Pharmaceut's value and its price as these two are different measures arrived at by different means. Investors typically determine if Manzo Pharmaceut is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Manzo Pharmaceut's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.